TITLE

Patent breakers

PUB. DATE
March 2008
SOURCE
Marketing Health Services;Spring2008, Vol. 28 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the results of a poll which was conducted by Harris Interactive for the online health industry edition of the "Wall Street Journal". The poll found that 57% of U.S. adults are in favor of Brazilian President Luiz Inacio Lula da Silva's decision to allow production of an inexpensive generic version of an AIDS drug which is manufactured by Merck & Co. The survey also found that 61% of U.S. adults believe that poorer countries should be able to break companies' patents on HIV/AIDS drugs if it would help in the treatment of patients. Other findings from the survey are discussed.
ACCESSION #
29973098

 

Related Articles

  • South Africa ground zero for reforming drug patents. Webster, Paul Christopher // CMAJ: Canadian Medical Association Journal;5/13/2014, Vol. 186 Issue 8, pE227 

    The article discusses the South African government's Draft National Policy on Intellectual Property that would limit the number of drug patents granted in the country and loosen restrictions on sales of generic drugs in the lead-up to the national elections on May 7, 2014. Topics covered include...

  • Harris poll hangs him high. Bond, Paul // Hollywood Reporter;1/27/2010, Vol. 413 Issue 7, p6 

    The article reports on the result of an annual survey conducted by Harris Interactive Inc. concerning the most popular actor in the U.S.

  • Display Blindness.  // Brandweek;12/13/2010, Vol. 51 Issue 44, p18 

    The article presents various reactions to a survey conducted with Harris Interactive which showed how banner advertisements are the most frequently ignored.

  • FDA actions.  // Infectious Disease Alert;Oct2012, Vol. 32 Issue 1, p2 

    The article offers updates on decisions issued by the U.S. Food and Drug Administration (FDA). The FDA approved Asthmanefrin-branded racepinephrine product for asthma marketed by Nephron Pharmaceuticals, RAYOS-branded prednisone marketed by Horizon Pharma, and Linzess-branded linaclotide...

  • CALIFORNIA DREAMIN' Gardyn, Rebecca // American Demographics;Oct2003, Vol. 25 Issue 8, p13 

    Presents the results of a 2003 survey conducted by Harris Interactive on the preferred dwelling place of people living in the U.S. State in which most people with they could live; Regions considered as the most popular dwelling preference by U.S. citizens; Ranks of the states of Texas and...

  • Coalition seeks quicker approval of generic Rxs.  // Drug Topics;8/7/95, Vol. 139 Issue 15, p24 

    Reports on the efforts by a coalition of consumer and industry groups to persuade the US Congress to overturn a decision by the US Food and Drug Administration. Postponement of anticipated generic competition for drugs such as Zantac and Capoten; Lobbying efforts by Gray Panthers, the National...

  • Canadian study eyes generic drugs' impact.  // Chain Drug Review;6/6/2011, Vol. 33 Issue 10, p1 

    The article presents the results of a study conducted by the University of British Columbia (UBC) which shows that Canada could save approximately 1.3 billion dollars annually if all its provinces were to follow Ontario's policy for reimbursing pharmacies for generic drugs.

  • Correction.  // CMAJ: Canadian Medical Association Journal;10/27/2009, Vol. 181 Issue 9, p617 

    A correction to the article "Ontario's law curbing the cost of generic drugs sparks changes for pharmacies and other Canadian buyers" that was published in the August 4, 2009 issue is presented.

  • ARCHAEOLOGY WORLD.  // American Schools of Oriental Research Newsletter;Summer2000, Vol. 50 Issue 2, p16 

    Presents news briefs related to developments in archaeology across the globe as of June 1, 2000. Purpose for which an ancient Cyprus webproject has been introduced by the Institute of Archaeology in London, England; Importance of archaeological sites and artifacts realized by Americans...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics